Ian Karp
Public Communications Contact chez INTELLIA THERAPEUTICS, INC.
Profil
Ian Karp is currently the Senior Vice President-Corporate Communications at Intellia Therapeutics, Inc. He previously worked as the Senior Director-Global Marketing at Medimmune, Inc. and as the Vice President & Head-Investor Relations at Shire Plc.
He also served as the Senior Vice President-Investor & Public Relations at Karyopharm Therapeutics, Inc. Mr. Karp received his undergraduate degree from Emory University and his MBA from Rutgers Business School.
Postes actifs de Ian Karp
| Sociétés | Poste | Début |
|---|---|---|
| INTELLIA THERAPEUTICS, INC. | Public Communications Contact | - |
Anciens postes connus de Ian Karp
| Sociétés | Poste | Fin |
|---|---|---|
| SHIRE | Investor Relations Contact | 01/12/2017 |
| Medimmune, Inc. | Sales & Marketing | - |
| KARYOPHARM THERAPEUTICS INC. | Investor Relations Contact | - |
Formation de Ian Karp
| Emory University | Undergraduate Degree |
| Rutgers Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| KARYOPHARM THERAPEUTICS INC. | Health Technology |
| INTELLIA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
| Medimmune, Inc. | Health Technology |
